The research shows that BGF1 can significantly inhibit the proliferation of HUVECs, 4T1 breast cancer cells, U87 glioblastoma cells, and SKOV3 ovarian cancer cells induced by FGF2, while the linear structure of BGF2 has no such effect [40]. Here, FGF2 is linked to ovarian carcinoma.